C

Cannabis Poland SA
WSE:CBD

Watchlist Manager
Cannabis Poland SA
WSE:CBD
Watchlist
Price: 0.301 PLN -5.94% Market Closed
Market Cap: 14.8m PLN
Have any thoughts about
Cannabis Poland SA?
Write Note

Gross Margin
Cannabis Poland SA

33.7%
Current
-12%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
33.7%
=
Gross Profit
97.1k
/
Revenue
287.8k

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
PL
Cannabis Poland SA
WSE:CBD
14.8m PLN
34%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
US
Eli Lilly and Co
NYSE:LLY
756.2B USD
81%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK
85%
US
Johnson & Johnson
NYSE:JNJ
351.2B USD
69%
US
Merck & Co Inc
NYSE:MRK
251.2B USD
77%
CH
Roche Holding AG
SIX:ROG
200.1B CHF
73%
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP
82%
CH
Novartis AG
SIX:NOVN
171.5B CHF
75%
US
Pfizer Inc
NYSE:PFE
151.1B USD
71%
Country PL
Market Cap 14.8m PLN
Gross Margin
34%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 351.2B USD
Gross Margin
69%
Country US
Market Cap 251.2B USD
Gross Margin
77%
Country CH
Market Cap 200.1B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 171.5B CHF
Gross Margin
75%
Country US
Market Cap 151.1B USD
Gross Margin
71%
No Stocks Found

Cannabis Poland SA
Glance View

Market Cap
14.8m PLN
Industry
Pharmaceuticals

Cannabis Poland SA engages in the production and distribution of cannabinoid vaporization equipment and oils. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2013-04-09. The firm focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The firm also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The firm is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.

CBD Intrinsic Value
0.016 PLN
Overvaluation 95%
Intrinsic Value
Price
C

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
33.7%
=
Gross Profit
97.1k
/
Revenue
287.8k
What is the Gross Margin of Cannabis Poland SA?

Based on Cannabis Poland SA's most recent financial statements, the company has Gross Margin of 33.7%.